Peter F. Lang
Directeur Financier/CFO chez OPTHEA LIMITED
Postes actifs de Peter F. Lang
Sociétés | Poste | Début | Fin |
---|---|---|---|
OPTHEA LIMITED | Directeur Financier/CFO | 27/10/2023 | - |
Historique de carrière de Peter F. Lang
Anciens postes connus de Peter F. Lang
Sociétés | Poste | Début | Fin |
---|---|---|---|
AERIE PHARMACEUTICALS, INC. | Directeur Financier/CFO | 18/03/2022 | 21/11/2022 |
Ridge Advisory LLC | Corporate Officer/Principal | - | - |
Formation de Peter F. Lang
The University of Chicago Booth School of Business | Masters Business Admin |
The Wharton School of the University of Pennsylvania | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 5 |
Australie | 2 |
Opérationnelle
Director of Finance/CFO | 2 |
Corporate Officer/Principal | 1 |
Masters Business Admin | 1 |
Sectorielle
Health Technology | 3 |
Consumer Services | 3 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
OPTHEA LIMITED | Health Technology |
Entreprise privées | 2 |
---|---|
Aerie Pharmaceuticals, Inc.
Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX. | Health Technology |
Ridge Advisory LLC | Commercial Services |
- Bourse
- Insiders
- Peter F. Lang
- Expérience